Why is Alkem Lab falling/rising?

As of 24-Sep, Alkem Laboratories Ltd is experiencing a price increase, currently at 5,581.95, reflecting a rise of 31.1 points or 0.56%. The stock has outperformed its sector by 1.01% today and has shown consecutive gains over the last two days, with a total return of 1.56% during this period. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Despite a year-to-date decline of 0.86% and a 1-year drop of 7.91%, the company has demonstrated a profit increase of 4.9% over the past year, contributing to its fair valuation relative to peers. However, concerns about long-term growth persist, as evidenced by modest net sales and operating profit growth rates over the last five years, alongside a decrease in promoter confidence due to a reduction in their stake.
In the broader market context, Alkem Laboratories has outperformed the Sensex in the short term, with a 1-week return of 2.20% compared to the benchmark's decline of 1.18%. This indicates that while the stock is facing some challenges, particularly regarding long-term growth prospects and promoter confidence, its recent performance has been relatively strong against the backdrop of a declining market. The liquidity of the stock, supported by a significant increase in delivery volume, further suggests that investor interest remains robust, which may be contributing to its upward price movement.